203 related articles for article (PubMed ID: 29382856)
21. Sphingosine-1-Phosphate Receptor-3 Supports Hematopoietic Stem and Progenitor Cell Residence Within the Bone Marrow Niche.
Ogle ME; Olingy CE; Awojoodu AO; Das A; Ortiz RA; Cheung HY; Botchwey EA
Stem Cells; 2017 Apr; 35(4):1040-1052. PubMed ID: 28026131
[TBL] [Abstract][Full Text] [Related]
22. Diabetes impairs hematopoietic stem cell mobilization by altering niche function.
Ferraro F; Lymperi S; Méndez-Ferrer S; Saez B; Spencer JA; Yeap BY; Masselli E; Graiani G; Prezioso L; Rizzini EL; Mangoni M; Rizzoli V; Sykes SM; Lin CP; Frenette PS; Quaini F; Scadden DT
Sci Transl Med; 2011 Oct; 3(104):104ra101. PubMed ID: 21998408
[TBL] [Abstract][Full Text] [Related]
23. Mobilization of hematopoietic stem cells into the peripheral blood.
Damon LE; Damon LE
Expert Rev Hematol; 2009 Dec; 2(6):717-33. PubMed ID: 21082960
[TBL] [Abstract][Full Text] [Related]
24. Functional potentials of human hematopoietic progenitor cells are maintained by mesenchymal stromal cells and not impaired by plerixafor.
Ludwig A; Saffrich R; Eckstein V; Bruckner T; Wagner W; Ho AD; Wuchter P
Cytotherapy; 2014 Jan; 16(1):111-21. PubMed ID: 24119647
[TBL] [Abstract][Full Text] [Related]
25. Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization.
Christopher MJ; Liu F; Hilton MJ; Long F; Link DC
Blood; 2009 Aug; 114(7):1331-9. PubMed ID: 19141863
[TBL] [Abstract][Full Text] [Related]
26. Adult stem cell mobilization enhances intramembranous bone regeneration: a pilot study.
McNulty MA; Virdi AS; Christopherson KW; Sena K; Frank RR; Sumner DR
Clin Orthop Relat Res; 2012 Sep; 470(9):2503-12. PubMed ID: 22528386
[TBL] [Abstract][Full Text] [Related]
27. Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells.
Pusic I; DiPersio JF
Curr Opin Hematol; 2010 Jul; 17(4):319-26. PubMed ID: 20473162
[TBL] [Abstract][Full Text] [Related]
28. Glycosaminoglycan mimetics-induced mobilization of hematopoietic progenitors and stem cells into mouse peripheral blood: structure/function insights.
Albanese P; Caruelle D; Frescaline G; Delbé J; Petit-Cocault L; Huet E; Charnaux N; Uzan G; Papy-Garcia D; Courty J
Exp Hematol; 2009 Sep; 37(9):1072-83. PubMed ID: 19539688
[TBL] [Abstract][Full Text] [Related]
29. Sphingosine-1-phosphate-mediated mobilization of hematopoietic stem/progenitor cells during intravascular hemolysis requires attenuation of SDF-1-CXCR4 retention signaling in bone marrow.
Mierzejewska K; Klyachkin YM; Ratajczak J; Abdel-Latif A; Kucia M; Ratajczak MZ
Biomed Res Int; 2013; 2013():814549. PubMed ID: 24490172
[TBL] [Abstract][Full Text] [Related]
30. Structural analogues of AMD3100 mobilise haematopoietic progenitor cells from bone marrow in vivo according to their ability to inhibit CXCL12 binding to CXCR4 in vitro.
Martin C; Bridger GJ; Rankin SM
Br J Haematol; 2006 Aug; 134(3):326-9. PubMed ID: 16787495
[TBL] [Abstract][Full Text] [Related]
31. Differential mobilization of subsets of progenitor cells from the bone marrow.
Pitchford SC; Furze RC; Jones CP; Wengner AM; Rankin SM
Cell Stem Cell; 2009 Jan; 4(1):62-72. PubMed ID: 19128793
[TBL] [Abstract][Full Text] [Related]
32. Role of CXCR4 chemokine receptor blockade using AMD3100 for mobilization of autologous hematopoietic progenitor cells.
Flomenberg N; DiPersio J; Calandra G
Acta Haematol; 2005; 114(4):198-205. PubMed ID: 16269859
[TBL] [Abstract][Full Text] [Related]
33. No evidence for cell activation or brain vaso-occlusion with plerixafor mobilization in sickle cell mice.
Choi E; Branch C; Cui MH; Yazdanbakhsh K; Mohandas N; Billett HH; Shi PA
Blood Cells Mol Dis; 2016 Mar; 57():67-70. PubMed ID: 26852658
[TBL] [Abstract][Full Text] [Related]
34. Recent advances on the use of the CXCR4 antagonist plerixafor (AMD3100, Mozobil™) and potential of other CXCR4 antagonists as stem cell mobilizers.
De Clercq E
Pharmacol Ther; 2010 Dec; 128(3):509-18. PubMed ID: 20826182
[TBL] [Abstract][Full Text] [Related]
35. Plerixafor improves the endothelial health balance. The effect of diabetes analysed by polychromatic flow cytometry.
Cappellari R; D'Anna M; Avogaro A; Fadini GP
Atherosclerosis; 2016 Aug; 251():373-380. PubMed ID: 27255499
[TBL] [Abstract][Full Text] [Related]
36. Ubiquitous overexpression of CXCL12 confers radiation protection and enhances mobilization of hematopoietic stem and progenitor cells.
Rajendiran S; Smith-Berdan S; Kunz L; Risolino M; Selleri L; Schroeder T; Forsberg EC
Stem Cells; 2020 Sep; 38(9):1159-1174. PubMed ID: 32442338
[TBL] [Abstract][Full Text] [Related]
37. Acute exercise mobilizes hematopoietic stem and progenitor cells and alters the mesenchymal stromal cell secretome.
Emmons R; Niemiro GM; Owolabi O; De Lisio M
J Appl Physiol (1985); 2016 Mar; 120(6):624-32. PubMed ID: 26744505
[TBL] [Abstract][Full Text] [Related]
38. Evidence for the involvement of sphingosine-1-phosphate in the homing and engraftment of hematopoietic stem cells to bone marrow.
Adamiak M; Borkowska S; Wysoczynski M; Suszynska M; Kucia M; Rokosh G; Abdel-Latif A; Ratajczak J; Ratajczak MZ
Oncotarget; 2015 Aug; 6(22):18819-28. PubMed ID: 26299919
[TBL] [Abstract][Full Text] [Related]
39. Stromal-derived factor-1/CXCR4 signaling: indispensable role in homing and engraftment of hematopoietic stem cells in bone marrow.
Sharma M; Afrin F; Satija N; Tripathi RP; Gangenahalli GU
Stem Cells Dev; 2011 Jun; 20(6):933-46. PubMed ID: 21186999
[TBL] [Abstract][Full Text] [Related]
40. Internal tandem duplication of Flt3 modulates chemotaxis and survival of hematopoietic cells by SDF1alpha but negatively regulates marrow homing in vivo.
Fukuda S; Pelus LM
Exp Hematol; 2006 Aug; 34(8):1041-51. PubMed ID: 16863910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
